Delivery Order SPE2DB22D3301-SPE2DB25FX8YS

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The contract has a ceiling value of $3,266.90 and a period of performance through November 20, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $1,516.35 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 mL cartridges. The $3,155.06 firm-fixed-price contract has a completion date of January 31, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a pharmaceutical product. The contract has a ceiling value of $2,272.09 and runs through June 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999...
This is a firm fixed-price delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,285.77, was awarded by the Defense Logistics Agency (DLA) for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication. The contract has an ultimate completion date of January 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,168.50 delivery order contract is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,062.66 firm fixed-price contract is for the supply of Imitrex 6 mg/0.5 ml cartridges to support U.S. government medical requirements. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2022. There is no set-aside designation noted for this award. Amerisourcebergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication, to support federal healthcare programs. The Delivery Order has a Firm Fixed Price of $3,524.88 and a completion date of June 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,564,171,029 units of Imitrex 6 mg/0.5 ml cartridges. The delivery order contract has a firm fixed price of $12,332.63 and a period of performance through April 5, 2024. There is no set-aside designation associated with this award. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty pharmaceutical product, with a ceiling value of $9,945.53 and a completion date of December 20, 2024. The contract is a delivery order with a firm fixed price pricing type. This award is not designated as a set-aside...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX8YS
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The firm-fixed-price contract has a ceiling value of $3,877.00 and an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated as a set-aside requirement.

Generated 5/21/25, 10:02 AM